Yuchao He

849 total citations
25 papers, 593 citations indexed

About

Yuchao He is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yuchao He has authored 25 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Yuchao He's work include MicroRNA in disease regulation (5 papers), RNA modifications and cancer (5 papers) and Cancer-related molecular mechanisms research (5 papers). Yuchao He is often cited by papers focused on MicroRNA in disease regulation (5 papers), RNA modifications and cancer (5 papers) and Cancer-related molecular mechanisms research (5 papers). Yuchao He collaborates with scholars based in China, Japan and United States. Yuchao He's co-authors include Hua Guo, Lisha Qi, Liwei Chen, Ziye Chen, Yi Luo, Dongming Liu, Lu Chen, Tianqiang Song, Ning Zhang and Yuanyuan Liu and has published in prestigious journals such as The FASEB Journal, Stem Cells and Advanced Science.

In The Last Decade

Yuchao He

23 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuchao He China 12 393 303 121 112 74 25 593
Zhe Yang China 15 407 1.0× 280 0.9× 101 0.8× 135 1.2× 74 1.0× 42 656
Ninghua Yao China 13 331 0.8× 266 0.9× 79 0.7× 117 1.0× 51 0.7× 43 516
Shunjie Xia China 9 534 1.4× 399 1.3× 98 0.8× 86 0.8× 67 0.9× 13 731
Senjun Zhou China 9 432 1.1× 298 1.0× 95 0.8× 107 1.0× 46 0.6× 12 605
Chun-Cai Gu China 13 635 1.6× 479 1.6× 90 0.7× 155 1.4× 73 1.0× 17 846
Juanni Li China 16 605 1.5× 405 1.3× 141 1.2× 112 1.0× 33 0.4× 39 814
Xiaoqian Jing China 19 442 1.1× 221 0.7× 94 0.8× 185 1.7× 82 1.1× 32 680
Lantian Tian China 11 301 0.8× 218 0.7× 85 0.7× 128 1.1× 61 0.8× 21 549
Yifeng Tian China 16 479 1.2× 413 1.4× 102 0.8× 203 1.8× 68 0.9× 37 775
I‐Hsiao Chung Taiwan 16 446 1.1× 373 1.2× 60 0.5× 75 0.7× 63 0.9× 18 644

Countries citing papers authored by Yuchao He

Since Specialization
Citations

This map shows the geographic impact of Yuchao He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuchao He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuchao He more than expected).

Fields of papers citing papers by Yuchao He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuchao He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuchao He. The network helps show where Yuchao He may publish in the future.

Co-authorship network of co-authors of Yuchao He

This figure shows the co-authorship network connecting the top 25 collaborators of Yuchao He. A scholar is included among the top collaborators of Yuchao He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuchao He. Yuchao He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Yuchao, Dongming Liu, Zhiqiang Han, et al.. (2025). Inhibition of Wnt/β-catenin increases anti-tumor activity by synergizing with sorafenib in hepatocellular carcinoma. Cell Death and Disease. 16(1). 466–466. 3 indexed citations
2.
He, Yuchao, Xiangdong Tian, Duo Zuo, et al.. (2025). Trilaciclib triggers a neutrophil-related immune response and sensitizes non-small cell lung cancer to anti-PD-1 therapy. Cell Reports Medicine. 6(11). 102434–102434. 1 indexed citations
3.
He, Yuchao, et al.. (2024). Research on Highway Pavement Crack Detection Method based on Efficient Multi-Scale Feature Combining and Hierarchical Boosting Model. Journal of Computer-Aided Design & Computer Graphics. 36(12). 2020–2028.
4.
He, Yuchao, Wenchen Gong, Yu Wang, et al.. (2024). CCDC34 maintains stemness phenotype through β-catenin-mediated autophagy and promotes EGFR-TKI resistance in lung adenocarcinoma. Cancer Gene Therapy. 32(1). 104–121. 2 indexed citations
5.
Wang, Yali, Yuchao He, Wenchen Gong, et al.. (2024). OVOL2 induces autophagy-mediated epithelial-mesenchymal transition by the ERK1/2 MAPK signaling in lung adenocarcinoma. iScience. 27(2). 108873–108873. 2 indexed citations
6.
He, Yuchao, Wenchen Gong, Yu Wang, et al.. (2024). PD-L1 induces autophagy and primary resistance to EGFR–TKIs in EGFR-mutant lung adenocarcinoma via the MAPK signaling pathway. Cell Death and Disease. 15(8). 555–555. 18 indexed citations
7.
Gong, Wenchen, Su Zhang, Xiangdong Tian, et al.. (2024). Tertiary lymphoid structures as a potential prognostic biomarker for combined hepatocellular–cholangiocarcinoma. Hepatology International. 18(4). 1310–1325. 8 indexed citations
8.
He, Yuchao, Zhiyong Liu, Wenchen Gong, et al.. (2023). The Combination of R848 with Sorafenib Enhances Antitumor Effects by Reprogramming the Tumor Immune Microenvironment and Facilitating Vascular Normalization in Hepatocellular Carcinoma. Advanced Science. 10(18). e2207650–e2207650. 20 indexed citations
9.
Chen, Liwei, Yuchao He, Zhiqiang Han, et al.. (2023). The impact of decreased expression of SVEP1 on abnormal neovascularization and poor prognosis in patients with intrahepatic cholangiocarcinoma. Frontiers in Genetics. 13. 1127753–1127753. 3 indexed citations
10.
He, Yuchao, Wenchen Gong, Yu Wang, et al.. (2023). Inetetamab, a novel anti-HER2 monoclonal antibody, exhibits potent synergistic anticancer effects with cisplatin by inducing pyroptosis in lung adenocarcinoma. International Journal of Biological Sciences. 19(13). 4061–4081. 20 indexed citations
11.
He, Yuchao, Jun Zhou, Hua Guo, et al.. (2023). Characterization and therapeutic perspectives of differentiation-inducing therapy in malignant tumors. Frontiers in Genetics. 14. 1271381–1271381. 6 indexed citations
12.
Hu, Xiaomeng, Yuchao He, Zhiqiang Han, et al.. (2022). PNO1 inhibits autophagy-mediated ferroptosis by GSH metabolic reprogramming in hepatocellular carcinoma. Cell Death and Disease. 13(11). 1010–1010. 62 indexed citations
13.
Chen, Ziye, Lu Chen, Bo Sun, et al.. (2021). LDLR inhibition promotes hepatocellular carcinoma proliferation and metastasis by elevating intracellular cholesterol synthesis through the MEK/ERK signaling pathway. Molecular Metabolism. 51. 101230–101230. 52 indexed citations
14.
Han, Zhiqiang, Dongming Liu, Lu Chen, et al.. (2021). PNO1 regulates autophagy and apoptosis of hepatocellular carcinoma via the MAPK signaling pathway. Cell Death and Disease. 12(6). 552–552. 38 indexed citations
15.
Liu, Dongming, Lin Li, Yajie Wang, et al.. (2020). PNO1, which is negatively regulated by miR-340-5p, promotes lung adenocarcinoma progression through Notch signaling pathway. Oncogenesis. 9(5). 58–58. 29 indexed citations
16.
Chen, Lu, Wenchen Gong, Bo Sun, et al.. (2019). Periostin mediates epithelial-mesenchymal transition through the MAPK/ERK pathway in hepatoblastoma. Cancer Biology and Medicine. 16(1). 89–89. 23 indexed citations
17.
He, Yuchao, Lu Chen, Lisha Qi, et al.. (2019). Cytosolic phospholipase A2α modulates cell-matrix adhesion via the FAK/paxillin pathway in hepatocellular carcinoma. Cancer Biology and Medicine. 16(2). 377–377. 10 indexed citations
18.
Chen, Lu, Yuchao He, Ziye Chen, et al.. (2018). HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway. Cell Death and Disease. 9(5). 513–513. 192 indexed citations
19.
Fu, Hui, Yuchao He, Lisha Qi, et al.. (2017). cPLA2α activates PI3K/AKT and inhibits Smad2/3 during epithelial–mesenchymal transition of hepatocellular carcinoma cells. Cancer Letters. 403. 260–270. 55 indexed citations
20.
Guo, Hua, Hui Fu, Lisha Qi, et al.. (2016). Expression of OVOL2 is related to epithelial characteristics and shows a favorable clinical outcome in hepatocellular carcinoma. OncoTargets and Therapy. Volume 9. 5963–5973. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhe Yang Breakdown of academic impact, for papers by Ninghua Yao Breakdown of academic impact, for papers by Shunjie Xia Breakdown of academic impact, for papers by Senjun Zhou Breakdown of academic impact, for papers by Chun-Cai Gu Breakdown of academic impact, for papers by Juanni Li Breakdown of academic impact, for papers by Xiaoqian Jing Breakdown of academic impact, for papers by Lantian Tian Breakdown of academic impact, for papers by Yifeng Tian Breakdown of academic impact, for papers by I‐Hsiao Chung
Rankless by CCL
2026